Recent Blog Posts

View Post: Combivent FAQ
2 hours ago by Meds  
I own copd. cant afford combivent. what is my alternitive? You tell your doctor. Most of the time they will give you samples that will hold you over. Then look up the PPA program to see if you can qualify for getting your prescriptions free . ... Combivent is also referred to as albuterol and ipratropium inhalation. … What is more successful, symbicort or combivent? or what is the most effective inhaler to relieve asthma? – There is no right or wrong answer here. ...
View Blog: Zillarx - http://www.zillarx.com/

---

View Post: New analysis shows SYMBICORT® improved airflow obstruction in ...
9 Nov 2009
On the day of screening, FEV1 was measured predose and 15-30 minutes after two inhalations of albuterol 90 mcg.1 Airflow obstruction for albuterol was assessed based on the proportion of patients who achieved ATS criteria 15-30 minutes postdose on the screening day.1 Airflow ... SYMBICORT 160/4.5 mcg is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. ...
View Blog: AZ US news feed - http://www.astrazeneca-us.com/

---

View Post: FDA warns of stolen albuterol sulfate and ipratropium bromide ...
18 Sep 2009
August 19, 2009. Forest Laboratories and Glenmark Pharmaceuticals announced top-line results from a Phase 2b dose range-finding study of oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD). ...
View Blog: Latest articles from MPR - http://www.empr.com/

---

View Post: Spiriva FAQ
21 Nov 2009 by Drugs FAQ  
Its predecessors include Atrovent (or ipratropium ), which was effectual, but short acting. Tiotropium, a long-acting antimuscarinic bronchodilator. It is vital to totally avoid the precipitating cause of COPD, which is invariably ...
View Blog: Drugs FAQ - http://drugsfaq.blogspot.com/

---

View Post: Pulmonary Disease, Chronic Obstructive Clinical Trial: A Study to ...
4 Nov 2009
The Purpose of this study is to assess the efficacy and safety of three strengths of the FF/GW642444 Inhalation Powder in subject with Chronic Obstructive Pulmonary Disease. .... with a known or suspected history of alcohol or drug abuse within the last 2 years; Medication prior to spirometry: Subjects who are medically unable to withhold their albuterol/salbutamol and/or their ipratropium for the 4-hour period required prior to spirometry testing at each study visit. ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: Family Ties: Living with COPD
Allergy and Asthma Network Mothers ...
5 Oct 2009 by admin   ...
View Blog: http://www.aanma.org/

---

View Post: Respiratory Therapy Cave: How should COPD be treated?
6 Oct 2009 by Freadom  
Nosocomial COPD. Nosocomial COPD If a patient is in the hospital, and he smoked once, then he should be diagnosed with COPD and given Q4 breathing treatments even if he has no signs of respiratory illness. ..... The most common medicines placed in a nebulizer cup are Albuterol or Xopenex (bronchodilators) Duoneb (Atrovent and Albuterol combination). Atrovent can also be mixed with Xopenex. Other medicines like Pulmicort and Mucomyst are also inhaled via a nebulizer. ...
View Blog: Respiratory Therapy Cave - http://respiratorytherapycave.blogspot.com/

---

View Post: USPharmacist.com > Managing Acute Exacerbations of COPD
20 Jul 2009
Exacerbations are an important outcome measure in chronic obstructive pulmonary disease (COPD) due to their profound effect on the patient's quality of life and prognosis. It has been estimated that patients with COPD suffer one to four .... ipratropium is recommended, every 6 hours as needed, even though evidence concerning the effectiveness of this combination is controversial.7 Common side effects that occur include tachycardia and tremor for albuterol and dry mouth ...
View Blog: Untitled - http://www.uspharmacist.com/home/

---

View Post: Perforomist Inhalation Solution Data Presented At American ...
28 Oct 2009 by admin  
In a separate poster presentation, results were presented from a post-hoc analysis conducted to assess the effects of age, gender and COPD severity on patient responses to Perforomist Inhalation Solution and ipratropium/albuterol MDI. ...
View Blog: Discuss Pharmacy - http://discusspharmacy.com/

---